Welcome to our dedicated page for Aterian SEC filings (Ticker: ATER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aterian, Inc. (Nasdaq: ATER) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Delaware corporation with publicly traded common stock, Aterian submits periodic and current reports that offer detail on its financial condition, operations, governance, and material events affecting the business.
Investors can review Aterian’s current reports on Form 8-K, which in the supplied data include earnings announcements for quarters ended June 30 and September 30, 2025, amendments to its Credit and Security Agreement, and disclosures related to executive and director changes. Other 8-K filings describe the company’s entry into a material definitive agreement with its lenders and the furnishing of press releases that summarize financial results and guidance.
The company’s definitive proxy statement on Schedule DEF 14A outlines matters submitted to stockholders at the 2025 annual meeting, such as the election of directors, ratification of the independent registered public accounting firm, and advisory votes on executive compensation and the frequency of such votes. This document also explains record dates, voting procedures, and other governance details.
Over time, Aterian’s filings set is expected to include annual reports on Form 10-K, quarterly reports on Form 10-Q, additional Forms 8-K, and related exhibits. On Stock Titan, AI-powered tools can help summarize lengthy filings, highlight key sections on liquidity, credit agreements, and governance decisions, and make it easier to understand how individual disclosures fit into Aterian’s broader financial and strategic picture. Users can also monitor new filings as they are posted to EDGAR, including any future documents related to the company’s announced review of strategic alternatives.
Aterian, Inc. provided an update on its ongoing review of strategic alternatives, which began in December 2025. The company reports that the process is progressing and that it is engaged in constructive discussions and evaluating various opportunities, with another update anticipated in mid-April.
The Board is formally exploring options to maximize shareholder value, including a potential sale of company assets, a sale of the company, a business combination, a merger or other strategic actions. Aterian has engaged A.G.P / Alliance Global Partners as financial advisor and Paul Hastings LLP as legal counsel, while emphasizing there is no assurance any specific transaction will occur or when the review will be completed.
Aterian, Inc. files its annual report describing a consumer products business built around online marketplaces, with about 86% of 2025 revenue generated through Amazon’s U.S. platform. The company sells home, kitchen, air quality and health and beauty products under brands such as Squatty Potty and PurSteam.
The filing highlights continued operating losses, negative cash flows and an auditor’s going-concern warning, alongside heavy dependence on Chinese suppliers and Amazon’s policies. In December 2025 the board began exploring strategic alternatives, including a potential sale or merger, while simultaneously cutting fixed costs and reducing headcount.
Aterian also discloses a February 2026 voluntary recall of PurSteam travel steamers and related class action litigation, covenant-sensitive reliance on a MidCap revolving credit facility, and renewed Nasdaq minimum bid-price noncompliance, with added risk from a proposed minimum market value rule that could trigger rapid delisting.
Aterian, Inc. entered into Amendment No. 5 to its existing Credit and Security Agreement. The original credit agreement, dated December 22, 2021, is between Aterian and certain subsidiaries as borrowers, lenders party from time to time, and Midcap Funding IV Trust as administrative agent.
The new amendment, dated March 13, 2026, modifies that prior credit arrangement, though specific changes are contained in the attached exhibit and not detailed in this text. The company filed the amendment as a material definitive agreement, signaling that the credit facility remains an important part of its financing structure.
Aterian, Inc. director William Kurtz received an equity award of 40,394 shares of common stock on January 23, 2026. The shares are restricted stock granted under Aterian’s 2018 Equity Incentive Plan and are subject to vesting, and the award was made in lieu of cash compensation for his service on the Board of Directors. The shares were acquired at a stated price of $0 per share, bringing his directly held beneficial ownership to 155,922 shares of Aterian common stock.
Aterian, Inc. reported that its Chief Financial Officer, Joshua O. Feldman, received an award of 120,000 shares of common stock on 01/23/2026. These shares are described as restricted stock granted under the company’s 2018 Equity Incentive Plan and are subject to vesting conditions. The filing notes that this award was made outside Aterian’s regular annual equity grant cycle and was approved by the Compensation Committee for retention purposes. Following this grant, Feldman beneficially owns 497,442 shares of Aterian common stock in direct ownership.
Aterian, Inc. reported that its Chief Executive Officer and director, Arturo Rodriguez, received an award of 50,000 shares of common stock on January 23, 2026. The filing shows these shares were acquired at a price of $0 per share, reflecting a grant rather than an open‑market purchase. After this award, Rodriguez beneficially owned 1,011,148 shares of Aterian common stock in total.
The grant consists of restricted common stock issued under Aterian’s 2018 Equity Incentive Plan and is subject to vesting conditions. According to the disclosure, the award was granted outside the company’s regular annual equity grant cycle and was approved by the Compensation Committee for retention purposes, indicating it is designed to help keep the CEO in his role over time.
Aterian, Inc. director equity grant reported
Aterian, Inc. director Susan E. Lattmann reported receiving 25,555 shares of common stock on 01/23/2026 at a stated price of $0 per share. These shares are restricted stock granted under Aterian’s 2018 Equity Incentive Plan and are subject to vesting. The award was provided in lieu of cash compensation for her service on the Board of Directors. Following this grant, she beneficially owns 162,465 shares of Aterian common stock in direct ownership.
Aterian, Inc. director Bari A. Harlam reported receiving an equity grant of 24,731 shares of common stock on January 23, 2026. The shares are described as restricted common stock granted under Aterian’s 2018 Equity Incentive Plan and are subject to vesting. The award was granted in lieu of cash compensation for Harlam’s service on the Board of Directors and was recorded at a price of $0 per share as a stock-based compensation grant rather than an open-market purchase. Following this grant, Harlam directly beneficially owned 161,991 shares of Aterian common stock.
Aterian, Inc. filed an amended Form 8-K to update Item 5.07, reporting the company’s decision on how often it will hold future non-binding advisory votes on executive compensation (say-on-pay). This amendment follows the 2025 annual meeting results and fulfills Item 5.07(d) disclosure requirements. No other changes were made to the prior Form 8-K. An Inline XBRL cover page file is included as Exhibit 104.
Aterian, Inc. reported Q3 2025 results with net revenue of $19,021 (thousands) and gross profit of $10,671 (thousands). Operating loss was $2,043 (thousands) and net loss was $2,281 (thousands), or $0.28 per share. Cash was $7,588 (thousands) at September 30, 2025, and year‑to‑date operating cash flow was $(9,853) (thousands).
The company disclosed substantial doubt about its ability to continue as a going concern, citing ongoing losses, tariff-driven cost pressures, and dependence on external capital. Aterian amended its MidCap credit facility on August 29, 2025, temporarily reducing the minimum liquidity covenant to $5.0M, increasing to $6.8M after delivering a qualifying liquidity certificate; it remained in compliance as of quarter‑end.
A fixed cost reduction plan announced on May 14, 2025 resulted in $1.8M restructuring charges year‑to‑date and is expected to generate $5–$6M in annualized savings. The company also accrued about $0.4M for product remediation costs. Shares outstanding were 10,207,835 as of September 30, 2025.